Showing results (1871-1880 of 2,093) with videos related to

Sort By:
Pageof 210
AIDS and Behavior|August 23, 2019
Differentiating Types of Self-Reported Alcohol AbstinenceKirsha S Gordon, Kathleen McGinnis, Cecilia Dao, et al.
European Urology Oncology|April 12, 2022
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNADouglas G Ward, Laura Baxter, Sascha Ott, et al.
AIDS and Behavior|March 11, 2018
Correction to: Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral TreatmentSean N Halpin, Edwin Clayton Carruth, Ramona P Rai, et al.
AIDS Care|June 11, 2021
Sociodemographic and clinical correlates of gabapentin receipt with and without opioids among a national cohort of patients with HIVBenjamin J Oldfield, Yu Li, Rachel Vickers-Smith, et al.
Journal of General Internal Medicine|January 25, 2003
Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?Carol M Ashton, Paul Haidet, Debora A Paterniti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trialsL E Flaherty, M Atkins, J Sosman, et al.
Journal of Substance Abuse Treatment|December 19, 2020
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jailMichael S Gordon, Shannon Gwin Mitchell, Thomas R Blue, et al.
Pain Research & Management|August 15, 2012
Intake assessment of problematic use of medications in a chronic noncancer pain clinicLeah R Pink, Andrew J Smith, Philip W H Peng, et al.
ESMO Open|August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumorsT A Yap, A D Choudhury, E Hamilton, et al.
British Journal of Haematology|May 10, 2006
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease statusHoward S Yeh, Haiming Chen, Steven J Manyak, et al.
Pageof 210